Question 1

What is Nao Medical's role in CABENUVA care? What if my doctor's office cannot administer CABENUVA?

Accepted Answer

CABENUVA is HIV treatment, not PrEP. The HIV clinician must verify eligibility, manage the regimen and provide the exact order and target date. An administration site may carry out an accepted order while the HIV clinician remains responsible for treatment. Confirm actual clinic capability, sourcing, records and missed-dose responsibility; keep your HIV follow-up and arrange the dose with the receiving clinic.

Question 2

Do I still keep seeing my HIV doctor?

Accepted Answer

An administration or monitoring service does not automatically replace the treating prescriber. Agree on who manages the diagnosis and other medicines, signs the treatment order, reviews laboratory results, records doses and handles missed visits or urgent symptoms. An outside clinician can remain involved when the services accept and coordinate that arrangement. Confirm the handoff before relying on a new service for a refill or injection.

Question 3

How often are CABENUVA injections scheduled?

Accepted Answer

Cabenuva is a complete injectable regimen of cabotegravir and rilpivirine used to replace an existing HIV-1 treatment regimen in eligible people whose virus is already suppressed. It is HIV treatment, not PrEP. A professional gives two injections into gluteal muscles at scheduled visits. Fewer daily pills can be helpful, but maintaining suppression still depends on attendance, laboratory monitoring and an uninterrupted treatment plan if injections stop.

The labeled indication includes adults and adolescents aged 12 or older who weigh at least 35 kg and have HIV RNA below 50 copies/mL on a stable regimen. It also requires no history of treatment failure and no known or suspected resistance to either medicine. The HIV clinician reviews prior regimens and resistance records, rather than relying on one recent viral-load result. Hepatitis B, pregnancy, interacting medicines, liver disease and ability to attend visits also affect the decision. Cabenuva does not treat hepatitis B.

The clinician responsible for HIV care confirms suppression, treatment history and suitability. Do not stop current tablets while a referral, authorization or delivery is pending.

Monthly and every-two-month injection schedules are available. An oral lead-in with both medicines is optional. The every-two-month pathway begins with two initiation visits one month apart before moving to the continuing calendar.

A referring HIV office and an alternative site of care may have different roles. Confirm the prescription, supply route, target date, labs, injection record and where urgent questions go. The administration site does not replace the HIV clinician who manages the regimen.

Arrange viral-load testing after the change and continuing treatment-safety review. The team needs a plan for travel, delays, side effects and return to another suppressive regimen if needed.

Question 4

Do you accept insurance for CABENUVA administration visits?

Accepted Answer

Have your insurance card ready when booking. Share member details through the clinic’s confirmed secure intake process. Check with the clinic and your insurer that the exact plan covers the clinician and requested service. Ask about visit charges, any separately billed tests or medicines, and any referral or authorization requirement. Coverage and your copay or deductible depend on the plan; request a written estimate if paying yourself.

Question 5

What if an injection may be missed by more than 7 days?

Accepted Answer

The schedule is monthly or every two calendar months, not a freely interchangeable eight-week interval. Tell both the HIV clinician and administration team immediately if a visit may be more than seven days late. Oral coverage or a different injection restart may be needed. If Cabenuva stops, another fully suppressive regimen must start on the label’s timeline: no later than one month after the final monthly injections or two months after the final every-two-month injections. Viral-load follow-up remains necessary.

The clinician responsible for HIV care confirms suppression, treatment history and suitability. Do not stop current tablets while a referral, authorization or delivery is pending.

Monthly and every-two-month injection schedules are available. An oral lead-in with both medicines is optional. The every-two-month pathway begins with two initiation visits one month apart before moving to the continuing calendar.

A referring HIV office and an alternative site of care may have different roles. Confirm the prescription, supply route, target date, labs, injection record and where urgent questions go. The administration site does not replace the HIV clinician who manages the regimen.

Arrange viral-load testing after the change and continuing treatment-safety review. The team needs a plan for travel, delays, side effects and return to another suppressive regimen if needed.

Question 6

What happens if an injection is late?

Accepted Answer

Call the HIV clinician and administration site with the exact dates. A delay beyond the permitted window may require oral therapy and clinical reassessment. Never assume the long-lasting medicine makes a gap harmless.

Question 7

Does a small detectable viral load mean the injections failed?

Accepted Answer

One result requires interpretation with earlier results, timing, adherence and possible interactions. Your HIV clinician decides when to repeat testing and whether resistance assessment or a treatment change is needed. A forum cannot establish that your result is harmless.

Question 8

How should I plan work around injections?

Accepted Answer

Discuss soreness, prior reactions, travel and the need to attend every appointment. Confirm the expected visit process with the site. Neither a standard amount of time off nor a promise of painless injections applies to everyone.